There are a couple of things I could say. One is that the responses we received were more of a historical nature. The questions we have are about how this particular waiver would work in this particular context. A lot of the comparisons are made to HIV medicines, which are very different from vaccines against COVID-19. The questions themselves don't lend themselves to talking about what happened in the past. We need to be thinking about what is the potential for this into the future. It's important to ask these questions—
On May 28th, 2021. See this statement in context.